The goals of this proposal are to determine the time of surveillance of DNA cross-links in the cell cycle and the timing and mechanism of repair of the cross-links in the cell cycle Bi-functional reagents such as cisplatin can cross-link DNA. Such damage interfere with cellular processes of transcription and replication and the agents are useful in treatment of cancer. Mechanisms for the repair of the DNA damage caused by cross-linking are not understood in eukaryotic cells. Cells from patients with the disease Fanconi anemia show a markedly increased sensitivity to agents which cross-link DNA, among all the forms of DNA damage tested. This illustrates the cross-links require specific steps for repair. Although yeast does not apparently contain orthologs to the Fanconi anemia genes isolated, because of the powerful genetic system and the detailed analysis of the cell cycle, yeast offers a good system for investigating eukaryotic response to DNA cross-links. This proposal will test whether or not DNA cross-links are surveyed and assessed at a particular point in the cell cycle, rather than throughout the cell cycle and whether or not the repair of DNA cross-links is segregated to a particular time in the cell cycle. This information is needed for understanding the mechanisms for DNA cross-link repair and the gene products which are involved. Ultimately we want to define the components regulating the cell cycle checkpoints for DNA cross-links. To develop these studies, we will isolate and characterize additional cross-linker sensitive mutants.
|Effective start/end date||8/1/98 → 7/31/03|
- National Institutes of Health: $182,632.00
- National Institutes of Health
- National Institutes of Health: $174,743.00
- National Institutes of Health: $178,723.00
- Biochemistry, Genetics and Molecular Biology(all)